Patents by Inventor Kfir SHARABI

Kfir SHARABI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective inhibition of gluconeogenic activity
    Patent number: 11247970
    Abstract: The present invention provides compounds, pharmaceutical compositions and methods for treating and/or preventing a metabolic condition, such as diabetes.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: February 15, 2022
    Assignees: Dana-Farber Cancer Institute, Inc., The Scripps Research Institute, The Broad Institute, Inc.
    Inventors: Pere Puigserver, Kfir Sharabi, Theodore Kamenecka, Patrick Griffin, Stuart L. Schreiber, Roger Schilling, Partha P. Nag, Joshua A. Bittker
  • SELECTIVE INHIBITION OF GLUCONEOGENIC ACTIVITY
    Publication number: 20200317620
    Abstract: The present invention provides compounds, pharmaceutical compositions and methods for treating and/or preventing a metabolic condition, such as diabetes.
    Type: Application
    Filed: March 21, 2018
    Publication date: October 8, 2020
    Applicants: Dana-Farber Cancer Institute, Inc., The Scripps Research Institute
    Inventors: Pere PUIGSERVER, Kfir SHARABI, Theodore KAMENECKA, Patrick GRIFFIN, Stuart L. SCHREIBER, Roger SCHILLING, Partha P. NAG, Joshua A. BITTKER